MedPath

propofol

These highlights do not include all the information needed to use PROPOFOL INJECTABLE EMULSION safely and effectively. See full prescribing information for PROPOFOL INJECTABLE EMULSION. PROPOFOL injectable emulsion, for intravenous use Initial U.S. Approval: 1991

Approved
Approval ID

fa93f173-7858-4d88-860e-76ab97e65c2f

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 3, 2023

Manufacturers
FDA

Sagent Pharmaceuticals

DUNS: 080579617

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

propofol

PRODUCT DETAILS

NDC Product Code25021-608
Application NumberANDA075102
Marketing CategoryC73584
Route of AdministrationINTRAVENOUS
Effective DateFebruary 3, 2023
Generic Namepropofol

INGREDIENTS (6)

propofolActive
Quantity: 10 mg in 1 mL
Code: YI7VU623SF
Classification: ACTIB
soybean oilInactive
Code: 241ATL177A
Classification: IACT
glycerinInactive
Code: PDC6A3C0OX
Classification: IACT
egg phospholipidsInactive
Code: 1Z74184RGV
Classification: IACT
sodium metabisulfiteInactive
Code: 4VON5FNS3C
Classification: IACT
sodium hydroxideInactive
Code: 55X04QC32I
Classification: IACT
© Copyright 2025. All Rights Reserved by MedPath
propofol - FDA Approval | MedPath